A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Madhavi, N.
- Variation in Total Ozone Content and Solar UV Index Over a High Altitude Station Bangalore for a Decade 2006-2015:A Qualitative Review
Authors
1 Department of Physics, G.S.T, GITAM University, Bangalore, Karnataka, IN
2 Department of Physics, G.I.T, GITAM University, Visakhapatnam, AP, IN
3 Department of Physics, VITS College (Eng), Visakhapatnam, AP, IN
4 Department of Statistics, Govt. Degree College, Rajhamundry, AP, IN
Source
International Journal of Innovative Research and Development, Vol 5, No 5 (2016), Pagination: 37-40Abstract
Bangalore is the third most populous cities of India with a total population of over 11.5 million. This city has witnessed a huge growth in its population between years 2001 (5.1 million) to 2016(11.5 million). Bangalore lies approximately at a height of 3000 ft. above sea level and positioned at 12.960N, 77.560E latitude and longitude. Because of its elevation it enjoys cool climatic conditions yearlong when compared to other stations in India. However huge increase in population enhances urbanization which leads to severe anthropogenic activity in this station. Keeping this in view an attempt was made to study the incoming solar ultraviolet radiation for the period 2006-2015 and its impact if any on this station. It is observed that the UV Index at Bangalore has a minimum value of 9.15 and a maximum value of 13.4 for this decade 2006-2015. This indicates that the city is receiving maximum ultraviolet radiation with high to very high risk. Keeping this in view measures need to be taken for safeguarding the people of Bangalore from ultraviolet radiation.
Keywords
Total Ozone Content, UV-Index, TEMIS, OMI.- Formulation and Evaluation of Mouth Dissolving Tablets of Carbamazepine
Authors
1 Department of Pharmaceutics, Bellamkonda Institute of Technology and Sciences, Podili, IN
2 Department of Pharm. Chemistry, QIS College of Pharmacy, Ongole, IN
Source
Asian Journal of Pharmacy and Technology, Vol 7, No 3 (2017), Pagination: 137-143Abstract
Carbamazepine is an anticonvulsant. It works by decreasing nerve impulses that cause seizures and pain. Carbamazepine is used to treat seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy. Carbamazepine is also used to treat bipolar disorder. Due to sudden onset of attack, it is necessary to formulate antiepileptics into such a delivery system, which provide immediate relief. Hence, the present investigation was undertaken with a view to develop mouth-dissolving tablets of Carbamazepine, which offers a new range of product having desired characteristics and intended benefits. In this study, the mouth dissolving tablets were prepared using two different technologies, direct compression method and solid dispersion technology. Tablets produced by direct compression method contain crospovidone as a super disintegrant and sorbitol as a sweetener. Solid dispersions of Carbamazepine with polyvinylpyrrolidone K-30 and polyethylene glycol 6000 in different weight ratios were prepared with a view to increase its water solubility. Carbamazepine solid dispersions with polyvinylpyrrolidone K-30 in 1:2 ratios of drug: carrier showed maximum drug release and hence, compressed along with other excipients into mouth dissolving tablet. The results compared for both the technologies showed that the Carbamazepine tablets prepared using solid dispersion technology was found to have good technological properties and satisfying and reproducible drug dissolution profiles. Moreover, the drug release was found to be comparable to the marketed dispersible tablet.Keywords
Carbamazepine, Mouth Dissolving Tablets, PVP K30, PEG 6000, Solid Dispersions, FT-IR, Dissolution Rate.References
- Seager H. Drug-delivery Products and the Zydis Fast-dissolving Dosage Form. J Pharm Pharmacol 1998; 50:375-382.
- Bradoo R, Shahani S, Poojary S, Deewan B, Sudarshan S. Fast Dissolving Drug Delivery Systems. JAMA India 2001; 4(10): 27-31.
- Bang L, Goa K. Carbamazepine: a review of its use in children with epilepsy. Paediatr Drugs 2003; 5(8): 557-73.
- Wellington K, Goa KL. Carbamazepine: an update of its efficacy in the management of epilepsy. CNS Drugs 2001; 15(2): 137-63.
- Toshifusa S, Hideshi S, Kenji H, Kunio I. Studies of rapidly disintegrating tablets in oral cavity using co ground mixtures of mannitol with crospovidone. Chem Pharm Bull 2002; 50(2): 193198.
- Franco M, Trapani G, Latrofa A et al. Dissolution properties and anticonvulsant activity of phenytoin-PEG 6000 and PVP K30 solid dispersion. Int J Pharm 2001; 225:63-73.
- Ahmad M Abdul-Fattah, Bhargva HN. Preparation and in vitro evaluation of solid dispersion of halofantrine. Int J Pharm 2002; 235:17-33.
- Van den Mooter G, Augustijns P, Blaton N, Kinget R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998; 164:67-80.
- Ryh-Nan P, Jing-Huey C, Rhei-Long C. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion system. Drug Dev Ind Pharm 2000; 26(9): 989-994.
- Dobetti L. Fast melting tablets: Development and technology. Pharm Tech Drug Delivery 2001; 44-50.
- Bi Y, Sunada H, Yonezawa Y, Danjo K, Iida K. Preparation and evaluation of compressed tablets rapidly disintegrating in the oral cavity. Chem Pharm Bull (Tokyo) 1996; 44: 2121-2127.
- Andries F. Marais, Mingna Song, Melgardt M. de Villiers. Effect of compression force, humidity and disintegrant concentration on the disintegration and dissolution of directly compressed furosemide tablets using croscarmellose sodium as disintegrant. Tropl J Pharm Res 2003; 2:125-135.
- Shenoy V, Agrawal S, Pandey S. Optimizing fast dissolving Dosage form of Diclofenac Sodium by rapidly disintegrating agents. Indian J Pharm Sci 2003; 65(2): 197-201.
- Debord B, Lefebvre C, Guyot Hermann AM, Bouche R, Guyot JC. Study of different crystalline forms of mannitol comparative behavior under compression. Drug Dev Ind Pharm 1987; 13:1533-1546.
- Pharmapedia.http://www.pharmpedia.com/Tablet:Formulation_of_tablets/Diluents.
- Patel DM, Patel NM, Shah RR, Jogani PD, Balapatel AI. Studies in formulation of orodispersible tablets of rofecoxib. Ind J Pharm Sci 2004; 66(5): 621-625.
- Najib NM, Suleiman M, Malakh A. Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions. Int J Pharm 1986; 32:229-236.
- Corrigan OI, Murphy CA, Timoney RF. Dissolution properties of polyethylene glycols and polyethylene glycol-drug systems. Int J Pharm 1979; 4:67-74.
- Dubois JL, Ford JL. Similarities in the release rates of different drugs from polyethylene glycol 6000 dispersions. J Pharm Pharmacol 1985; 37:494-495.
- Craig DQM, Newton JM. The dissolution of nortriptyline hydrochloride from polyethylene glycol solid dispersions. Int J Pharm 1992; 78:175-182.
- Saers Sjokvist E, Craig DQM. An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions. Int J Pharm 1992; 83:211219
- Stability Indicating UPLC Method for Simultaneous Estimation of Epalrestat and Pregabalin in Tablet Dosage Form
Authors
1 PG Department of Chemistry, JKC College, Guntur, Andhra Pradesh, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 2 (2019), Pagination: 489-494Abstract
A stability indicating ultra pressure liquid chromatographic method was developed and validated for the simultaneous estimation of Epalrestat and Pregabalin in bulk and tablet dosage form. The study was performed using HSS column (100mm x 2.1 mm, 1.8), with a mobile phase consisting of 0.1% o-phosphoric acid buffer (55% v/v) and acetonitrile (45%v/v) at a flow rate of 0.3ml/min.The detection was carried at 210 nm using PDA detector and the retention times were found to be 1.704 and 1.084 min for Epalrestat and Pregabalin respectively. The method was found to be linear in the concentration range of 37.5–225 μg/ml for Epalrestat and Pregabalin with r2= 0.999.These drugs were subjected to stress conditions such as acidic, basic, peroxide, thermal and photo degradation. The method was validated according to ICH guidelines.Keywords
Epalrestat, Pregabalin, UPLC, Degradation, ICH.References
- Nađa Kostic, Yannis Dotsikas, Nebojša Jović, Galina Stevanović, Anđelija Malenović and Mirjana Medenica. Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC–MS/MS methods. Journal of Pharmaceutical and Biomedical Analysis.2015;109:79-84.
- RitvaKarinen, Vigdis Vindenes, Inger Hasvold, Kirsten Midtbøen Olsen, Asbjørg S. Christophersen and Elisabeth Oiestad. Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology cases. 2015;7(7):634-644.
- Kasawar GB and Farooqui MN. Development and Validation of HPLC Method for the Determination of Pregabalin in Capsules. Indian Journal of Pharmaceutical Sciences. 2010;72(4):517-519.
- Anil Mohan J, Rajkumar B, Bhavya T and Ashok Kumar A. RP-HPLC method Development and validation for the simultaneous quantitative estimation of pregabalin, mecobalamin and alpha lipoic acid in capsules. Internationals Journal of Pharmacy and Pharmaceutical Sciences. 2014;6(1):270-277.
- Jampala Balaji, Bandi Ramachandra and Naidu NVS. Analytical RP-HPLC Method for Development and Validation of Pregabalin in bulk and the determination of pregabalin in capsule dosage form. International Journal of Innovative Research in Science, Engineering and Technology. 2014;3(4):11094-11098.
- Vaishali, Vikas Singh, Rajnish Kumar Singh, Ramesh Kumar Gupta, SudhansuRanjan Swain and JagannathSahoo. Development and validation of RP-HPLC method for the Assay of Pregabalin capsule. World Journal of Pharmaceutical Sciences. 2013;3(1):703-711.
- Naresh Chandra Reddy M and Chandra Sekhar K. RP-HPLC Determination of Related substances of Pregabalin in bulk and pharmaceutical dosage form. International Journal of Chemical and Pharmaceutical Sciences. 2012;3(2):40-46.
- Sneha P and PrathimaSrinivas. Stability indicating assay method development and validation of pregabalin in pharmaceutical dosage forms by RP-HPLC. Indo American J of Pharm Sci. 2015;2(6):1038-1047.
- Atta AM, Mostafa S, Salama I and Gomaa MS. A new HPLC method for simultaneous determination of atenolol and pregabalin in dosage forms and in human urine. International Journal of pharmaceutical, chemical and biological sciences. 2016;6(1):48-61.
- Sowjanya P. RP HPLC Method Development of Pregablin in Bulk, Dosage Form and Validation Parameters. Journal of Hospital and Clinical Pharmacy. 2016;2(4):61-75.
- MadhuHarikaB andRajendra Prasad Y. Development and Validation of Stability Indicating RP-HPLC method for simultaneous estimation of Epalrestat and Pregabalin in bulk and tablet dosage form. Int J Pharm. 2017; 7(2): 157-164.
- Mili Patel, Bhakti J Ladva, Sagar S Patel, Bhavesh S Nayak, Hetal K Patel and Bhumi R Patel. Stability indicating HPLC method for simultaneous estimation of Epalrestat and Methylcobalamin in tablet dosage form. International Journal of Recent Scientific Research Research. 2015;6(4):3673-3678.
- Atul A. Shirkhedkar, Chetan S. Nankar, Sanjay J. Surana. Quantitative determination of Epalrestat by RP-HPLC method. Eurasian J Anal Chem. 2012;7(1): 49-55.
- Mili Patel, Bhakti J Ladva, Vijay Mahida, Bhavesh S Nayak, Hetal K Patel and Bhumi R Patel. Development and validation of RP-HPLC method for simultaneous estimation of epalrestat and methylcobalamin in tablet dosage form. World Journal of Pharmaceutical Sciences. 2015;4(1):574-584.
- Krima R Patel, Dimal A Shah, Falgun A Mehta, Usmangani K. Chhalotiya, Kashyap K Bhatt. Liquid Chromatographic Estimation of Epalrestat and Methylcobalamin in Pharmaceutical Formulation.Research and Reviews: Journal of Pharmaceutical Analysis. 2014;3(2):35-42.
- JanakiPathi P andAppalaRaju N.The Estimation of Epalrestat in Tablet Dosage Form by RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2012;2(2):1-3.
- Jogi Naga Kumari. Development and validation of new RP-HPLC method for simultaneous estimation of drug Duloxetine and Mecobalamin in tablet dosage form. Indian Journal of Research in Pharmacy and Biotechnology. 2016;4(4):169-179.
- Bari NM, Khan ZG and Patil DD. Analytical Methodologies for Determination of Methylcobalamin: An Overview. Austin J Anal Pharm Chem. 2016;3(1):1062-1067.
- AkshayTripathi, R.P.S Rathor, P.R.Kamble, GirishVyas. Reverse Phase HPLC Method for Estimation of Acelofenac and Pregabaline in Combined Dossage Form. International Journal of Pharmamedix India. 2014;2(3):764-780.
- PrashantPingale and Tanmay Singasane. Development and validation of HPLC method for the determination of pregabalin in bulk and in pharmaceutical formulations. Research Journal of Pharmacy and Technology. 2012;5(6):829-833.
- Ashutosh Kumar S, Manidipa Debnath, Seshagiri Rao JVLN and Gowri Sankar D. Stability Indicating Analytical Method Development and Validation for Simultaneous Estimation of Pregabalin, Mecobalamin and Alpha Lipoic Acid in Bulk as well as in Pharmaceutical Dosage Form by using RP-HPLC. Research Journal of Pharmacy and Technology. 2014;7(9):1004-1013.
- Eswara Rao Bammidi ,Vaikuntarao Lakinani, Subrahmanyam Lanka, Pavitra Paila and Mallikarjun Rao Duvvada. Development, Validation & Degradation Studies of RP-HPLC Method for the Determination of Pregabalin in Oral Suspension Powder. International Journal of Medicine and Pharmaceutical Research. 2015, 3(5): 1151–1156.
- Saravanan J, Shajan A, Joshi NH, Varatharajan R and Valliappan K. A Simple and validated RP-HPLC method for the estimation of methylcobalamin in bulk and capsule dosage form. International Journal of Chemical and Pharmaceutical Sciences. 2010;1(2):13-16.
- Ankita Bhavsar, Dhwani Shah, Tejal Solanki, Nikunj Sevak and RamkishanAjmeer. Development and validation of RP- HPLC method for simultaneous estimation of Aceclofenc and Pregabalin in combined tablet dosage form. Pharmaceutical And Biological Evaluations. 2015;2(4):91-97.
- Souri E, Eskandari M, BarazandehTehrani M, Adib N and Ahmadkhaniha R. HPLC Determination of Pregabalin in Bulk and Pharmaceutical Dosage Forms After Derivatization with 1-Fluoro-2,4-dinitrobenzene. Asian Journal of Chemistry. 2013;25(13):7332-7336.
- Saeed Arayne M, Hina Shahnaz, Amir Ali and Najma Sultana. Monitoring of Pregabalin in Pharmaceutical Formulations and Human Serum Using UV and RP-HPLC Techniques: Application to Dissolution Test Method. 2014;5(2):1000287.
- Krishna Chaitanya Prasad M, VidhyaSagar G and Sudhakar P. Simultaneous HPTLC method for estimation of gabapentin and pregabalin. International Journal of Pharmacy and Pharmaceutical Sciences. 2013;5(4):326-333.
- Dipak D Patil, Mukesh S Patil and Yogita B Wani. Spectrophotometric method for pregabalin determination: An experimental design approach for method development. Journal of the Association of Arab Universities for Basic and Applied Sciences. 2016;21:31-37.
- Dilip G. Maheshwari and KevalChaudhari. Development and Validation of UV Spectrophotometric Method for Simultaneous estimation of Epalrestat and Methylcobalamin in the Pharmaceutical Dosage Form. International Journal of PharmTech Research. 2014;6(4):1180-1188.
- MukthinuthalapatiMathrusri Annapurna, MalineniSushmitha and KunalaAnusha. New Analytical Techniques for the Determination of Epalrestat in Pharmaceutical Dosage forms by Spectrophotometry. Research Journal of Pharmacy and Technology. 2017;10(3):739-742.
- Maheshwari DG and Chaudhari KL. Dual wavelength spectrophotometric method for simultaneous estimation of epalrestat and methylcobalamin in bulk and combined dosage form. International Journal of Research in Pharmacy and Science. 2013;4(3):1-5.
- Mohamed Rizk, Mona S Elshahed, Ali K. Attia and Amir S Farag. Spectrophotometric determination of pregabalin using n-(1-naphthyl) ethylenediamine, as uvlabeling reagent. IJPBS. 2015;5(2):152-162.
- SowjanyaK, ThejaswiniJC, Gurupadayya BM and IndupriyaM. Spectrophotometric determination of Pregabalin using 1, 2-Napthaquinone-4- sulfonic acid Sodium and 2, 4 dinitrophenyl hydrazine in pharmaceutical dosage form. Der Pharmacia Lettre. 2011;3(2):47-56.
- Vovk T, Martinc B and Grabnar I. A Simple High-Throughput Method for Determination of Pregabalin in Pharmaceutical Dosage Forms using a Microplate Fluorescence Reader. Sci Pharm. 2010;78:704.
- Santosh G Shep andLahotiSR. Development and Validation of UV Spectrophotometric Method of Pregabalin In Bulk And Pharmaceutical Formulation. International Journal of PharmTech Research. 2013;5(3):1264-1270.
- ICH(2005) ICH Harmonised Tripartite Guidelines Q2(R1):Validation of analytical procedures.ICh,geneva.http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002662.pdf.